KCNH2 and cancer: For the first time, we demonstrate that pharmacologically activating the Kv11.1 potassium channel suppresses breast tumor metastasis in vivo and inhibits migration of ER-negative BC cells by reversing the EMT phenotype and cancer cell stemness.